JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Couturier, C.
Right arrow Articles by Andréani, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Couturier, C.
Right arrow Articles by Andréani, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 33, 23085-23093, August 13, 1999

Interleukin 1beta Induces Type II-secreted Phospholipase A2 Gene in Vascular Smooth Muscle Cells by a Nuclear Factor kappa B and Peroxisome Proliferator-activated Receptor-mediated Process

Cyril Couturier, Arthur Brouillet, Cécile Couriaud, Kamen Koumanov, Gilbert Béréziat, and Marise Andréani

From the Unité Propre de Recherche de l'Université Pierre et Marie Curie, Associée au CNRS, ESA7079, 7 quai St. Bernard, 75252 Paris, Cedex 5, France

Type II-secreted phospholipase A2 (type II-sPLA2) is expressed in smooth muscle cells during atherosclerosis or in response to interleukin-1beta . The present study shows that the induction of type II-sPLA2 gene by interleukin-1beta requires activation of the NFkappa B pathway and cytosolic PLA2/PPARgamma pathway, which are both necessary to achieve the transcriptional process. Interleukin-1beta induced type II-sPLA2 gene dose- and time-dependently and increased the binding of NFkappa B to a specific site of type II-sPLA2 promoter. This effect was abolished by proteinase inhibitors that block the proteasome machinery and NFkappa B nuclear translocation. Type II-sPLA2 induction was also obtained by free arachidonic acid and was blocked by either AACOCF3, a specific cytosolic-PLA2 inhibitor, PD98059, a mitogen-activated protein kinase kinase inhibitor which prevents cytosolic PLA2 activation, or nordihydroguaiaretic acid, a lipoxygenase inhibitor, but not by the cyclooxygenase inhibitor indomethacin, suggesting a role for a lipoxygenase product. Type II-sPLA2 induction was obtained after treatment of the cells by 15-deoxy-Delta 12,14-dehydroprostaglandin J2, carbaprostacyclin, and 9-hydroxyoctadecadienoic acid, which are ligands of peroxisome proliferator-activated receptor (PPAR) gamma , whereas PPARalpha ligands were ineffective. Interleukin-1beta as well as PPARgamma -ligands stimulated the activity of a reporter gene containing PPARgamma -binding sites in its promoter. Binding of both NFkappa B and PPARgamma to their promoter is required to stimulate the transcriptional process since inhibitors of each class block interleukin-1beta -induced type II-sPLA2 gene activation. We therefore suggest that NFkappa B and PPARgamma cooperate at the enhanceosome-coactivator level to turn on transcription of the proinflammatory type II-sPLA2 gene.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Couturier, C. Sarkis, K. Seron, S. Belouzard, P. Chen, A. Lenain, L. Corset, J. Dam, V. Vauthier, A. Dubart, et al.
Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity
PNAS, December 4, 2007; 104(49): 19476 - 19481.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Clement, M. Gueguen, M. Glorian, R. Blaise, M. Andreani, C. Brou, P. Bausero, and I. Limon
Notch3 and IL-1beta exert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-{kappa}B drives crosstalk
J. Cell Sci., October 1, 2007; 120(19): 3352 - 3361.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kuwata, C. Fujimoto, E. Yoda, S. Shimbara, Y. Nakatani, S. Hara, M. Murakami, and I. Kudo
A Novel Role of Group VIB Calcium-independent Phospholipase A2 (iPLA2{gamma}) in the Inducible Expression of Group IIA Secretory PLA2 in Rat Fibroblastic Cells
J. Biol. Chem., July 13, 2007; 282(28): 20124 - 20132.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Bonofiglio, S. Aquila, S. Catalano, S. Gabriele, M. Belmonte, E. Middea, H. Qi, C. Morelli, M. Gentile, M. Maggiolini, et al.
Peroxisome Proliferator-Activated Receptor-{gamma} Activates p53 Gene Promoter Binding to the Nuclear Factor-{kappa}B Sequence in Human MCF7 Breast Cancer Cells
Mol. Endocrinol., December 1, 2006; 20(12): 3083 - 3092.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Jaulmes, S. Thierry, B. Janvier, M. Raymondjean, and V. Marechal
Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1{beta}
FASEB J, August 1, 2006; 20(10): 1727 - 1729.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. V. Podgoreanu, G. A. Michelotti, Y. Sato, M. P. Smith, S. Lin, R. W. Morris, H. P. Grocott, J. P. Mathew, and D. A. Schwinn
Differential cardiac gene expression during cardiopulmonary bypass: Ischemia-independent upregulation of proinflammatory genes
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 330 - 339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kuwata, T. Nonaka, M. Murakami, and I. Kudo
Search of Factors That Intermediate Cytokine-induced Group IIA Phospholipase A2 Expression through the Cytosolic Phospholipase A2- and 12/15-Lipoxygenase-dependent Pathway
J. Biol. Chem., July 8, 2005; 280(27): 25830 - 25839.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Jaulmes, B. Janvier, M. Andreani, and M. Raymondjean
Autocrine and Paracrine Transcriptional Regulation of Type IIA Secretory Phospholipase A2 Gene in Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1161 - 1167.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Schlezinger, G. J. Howard, C. H. Hurst, J. K. Emberley, D. J. Waxman, T. Webster, and D. H. Sherr
Environmental and Endogenous Peroxisome Proliferator-Activated Receptor {gamma} Agonists Induce Bone Marrow B Cell Growth Arrest and Apoptosis: Interactions between Mono(2-ethylhexyl)phthalate, 9-cis-Retinoic Acid, and 15-Deoxy-{Delta}12,14-prostaglandin J2
J. Immunol., September 1, 2004; 173(5): 3165 - 3177.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Alvarez-Maqueda, R. E. Bekay, G. Alba, J. Monteseirin, P. Chacon, A. Vega, J. Martin-Nieto, F. J. Bedoya, E. Pintado, and F. Sobrino
15-Deoxy-{Delta}12,14-prostaglandin J2 Induces Heme Oxygenase-1 Gene Expression in a Reactive Oxygen Species-dependent Manner in Human Lymphocytes
J. Biol. Chem., May 21, 2004; 279(21): 21929 - 21937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Beck, G. Lambeau, K. Scholz-Pedretti, M. H. Gelb, M. J. W. Janssen, S. H. Edwards, D. C. Wilton, J. Pfeilschifter, and M. Kaszkin
Potentiation of Tumor Necrosis Factor {alpha}-induced Secreted Phospholipase A2 (sPLA2)-IIA Expression in Mesangial Cells by an Autocrine Loop Involving sPLA2 and Peroxisome Proliferator-activated Receptor {alpha} Activation
J. Biol. Chem., August 8, 2003; 278(32): 29799 - 29812.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Lappas, M. Permezel, and G. E. Rice
N-Acetyl-Cysteine Inhibits Phospholipid Metabolism, Proinflammatory Cytokine Release, Protease Activity, and Nuclear Factor-{kappa}B Deoxyribonucleic Acid-Binding Activity in Human Fetal Membranes in Vitro
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1723 - 1729.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Bousserouel, A. Brouillet, G. Bereziat, M. Raymondjean, and M. Andreani
Different effects of n-6 and n-3 polyunsaturated fatty acids on the activation of rat smooth muscle cells by interleukin-1{beta}
J. Lipid Res., March 1, 2003; 44(3): 601 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Schlezinger, B. A. Jensen, K. K. Mann, H.-Y. Ryu, and D. H. Sherr
Peroxisome Proliferator-Activated Receptor {gamma}-Mediated NF-{kappa}B Activation and Apoptosis in Pre-B Cells
J. Immunol., December 15, 2002; 169(12): 6831 - 6841.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Bishop-Bailey, T. Hla, and T. D. Warner
Intimal Smooth Muscle Cells as a Target for Peroxisome Proliferator-Activated Receptor-{gamma} Ligand Therapy
Circ. Res., August 9, 2002; 91(3): 210 - 217.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Barbier, I. P. Torra, Y. Duguay, C. Blanquart, J.-C. Fruchart, C. Glineur, and B. Staels
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 717 - 726.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Alaoui-El-Azher, Y. Wu, N. Havet, A. Israel, A. Lilienbaum, and L. Touqui
Arachidonic Acid Differentially Affects Basal and Lipopolysaccharide-Induced sPLA2-IIA Expression in Alveolar Macrophages through NF-kappa B and PPAR-gamma -Dependent Pathways
Mol. Pharmacol., April 1, 2002; 61(4): 786 - 794.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-M. Zingg, R. Ricciarelli, E. Andorno, and A. Azzi
Novel 5' Exon of Scavenger Receptor CD36 Is Expressed in Cultured Human Vascular Smooth Muscle Cells and Atherosclerotic Plaques
Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 412 - 417.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Scholz-Pedretti, A. Gans, K.-F. Beck, J. Pfeilschifter, and M. Kaszkin
Potentiation of TNF-{alpha}-Stimulated Group IIA Phospholipase A2 Expression by Peroxisome Proliferator-Activated Receptor {alpha} Activators in Rat Mesangial Cells
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 611 - 620.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. G. Harris, R. S. Smith, and R. P. Phipps
15-Deoxy-{Delta}12,1412,14-PGJ2 Induces IL-8 Production in Human T Cells by a Mitogen-Activated Protein Kinase Pathway
J. Immunol., February 1, 2002; 168(3): 1372 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Degousee, E. Stefanski, T. F. Lindsay, D. A. Ford, R. Shahani, C. A. Andrews, D. J. Thuerauf, C. C. Glembotski, T. J. Nevalainen, J. Tischfield, et al.
p38 MAPK Regulates Group IIa Phospholipase A2 Expression in Interleukin-1beta -stimulated Rat Neonatal Cardiomyocytes
J. Biol. Chem., November 16, 2001; 276(47): 43842 - 43849.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Kuwata, S. Yamamoto, Y. Miyazaki, S. Shimbara, Y. Nakatani, H. Suzuki, N. Ueda, S. Yamamoto, M. Murakami, and I. Kudo
Studies on a Mechanism by Which Cytosolic Phospholipase A2 Regulates the Expression and Function of Type IIA Secretory Phospholipase A2
J. Immunol., October 1, 2000; 165(7): 4024 - 4031.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
U. Ikeda, M. Shimpo, Y. Murakami, and K. Shimada
Peroxisome Proliferator-Activated Receptor-{gamma} Ligands Inhibit Nitric Oxide Synthesis in Vascular Smooth Muscle Cells
Hypertension, June 1, 2000; 35(6): 1232 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Sartipy, B. Johansen, K. Gasvik, and E. Hurt-Camejo
Molecular Basis for the Association of Group IIA Phospholipase A2 and Decorin in Human Atherosclerotic Lesions
Circ. Res., March 31, 2000; 86(6): 707 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Peilot, B. Rosengren, G. Bondjers, and E. Hurt-Camejo
Interferon-gamma Induces Secretory Group IIA Phospholipase A2 in Human Arterial Smooth Muscle Cells. INVOLVEMENT OF CELL DIFFERENTIATION, STAT-3 ACTIVATION, AND MODULATION BY OTHER CYTOKINES
J. Biol. Chem., July 21, 2000; 275(30): 22895 - 22904.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Murakami, R. S. Koduri, A. Enomoto, S. Shimbara, M. Seki, K. Yoshihara, A. Singer, E. Valentin, F. Ghomashchi, G. Lambeau, et al.
Distinct Arachidonate-releasing Functions of Mammalian Secreted Phospholipase A2s in Human Embryonic Kidney 293 and Rat Mastocytoma RBL-2H3 Cells through Heparan Sulfate Shuttling and External Plasma Membrane Mechanisms
J. Biol. Chem., March 23, 2001; 276(13): 10083 - 10096.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Akiba, R. Hatazawa, K. Ono, K. Kitatani, M. Hayama, and T. Sato
Secretory Phospholipase A2 Mediates Cooperative Prostaglandin Generation by Growth Factor and Cytokine Independently of Preceding Cytosolic Phospholipase A2 Expression in Rat Gastric Epithelial Cells
J. Biol. Chem., June 8, 2001; 276(24): 21854 - 21862.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.